AG 02 saporin conjugate
Alternative Names: AG 02 saporin antibody drug conjugate - A&G Pharmaceutical; AG02; AG02 ADCLatest Information Update: 28 Apr 2023
At a glance
- Originator A&G Pharmaceutical
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mesothelioma
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for preclinical development in Mesothelioma in USA (Parenteral)
- 29 Mar 2019 Pharmacodynamics data from a preclinical trial in Mesothelioma presented at the 110th Annual Meeting of the American Association for Cancer Research (AACR-2019)
- 01 Mar 2019 Preclinical trials in Mesothelioma in USA (Parenteral), before March 2019